Results 61 to 70 of about 38,444 (194)
Guillain-Barré syndrome with transition from hashimoto's to graves' disease: a case report
Background On rare occasions, there can be a transition from Hashimoto's to Graves' disease. However, there are no reported cases of transition from Hashimoto's to Graves' disease triggered by the onset of Guillain-Barré syndrome.
Mari Asano, Tsuneaki Kenzaka
doaj +1 more source
This is a report of a 50 year-old Thai male who was admitted to Siriraj Hospital because of progressive weakness of all extremities and increase shortness of breath. Endotracheal tube intubation was introduced for ventilatory support and secretion clearance.
Thanet Chaisathaphol, Jamsak Tscheikuna
openaire +1 more source
RVD with weekly bortezomib dosing in real‐world newly diagnosed transplant‐ineligible myeloma shows comparable efficacy and reduced toxicity compared to twice‐weekly trial protocols. ABSTRACT Background Lenalidomide, bortezomib, and dexamethasone (RVD) remains a standard of care regimen for newly diagnosed multiple myeloma in centers without access to ...
Samantha Kurniawan +17 more
wiley +1 more source
Guillain-Barré syndrome is an immune-mediated polyneuropathy that frequently presents with progressive muscle weakness. Hyponatremia has recently been described as a feature of this condition, generally appearing over the course of the illness and ...
Benjamin Kloesel, LaTonya J. Hickson
doaj +1 more source
Clinical Burden of Symptomatic HEV‐3 Infection in Southern Spain
Clinical burden of symptomatic HEV‐3 infection in southern Spain. Between 2022 and 2025, 1124 patients with acute hepatitis, defined as ALT ≥ 3 times the upper limit of normal and negative screening for HAV, HBV, HCV, EBV and CMV, were evaluated in Andalusia.
María Casares‐Jimenez +14 more
wiley +1 more source
High doses of immunoglobulin g in the therapy for severe forms of myasthenia gravis and Guillain-Barré syndrome [PDF]
Background/Aim. High doses of immunoglobulin G (IVIG) have been recognized as a very important therapeutic modality in the treatment of neurological diseases.
Lavrnić Dragana +9 more
doaj +1 more source
Untargeted multiomic profiling of cerebrospinal fluid reveals that proteomic, but not lipidomic, signatures robustly distinguish ALS patients from controls and stratify individuals by survival, highlighting marked molecular differences between short survival and long survival disease.
Sergio Roca‐Pereira +19 more
wiley +1 more source
Síndrome de Guillain-Barré, reporte de un caso en un lactante mayor y revisión de la literatura
Introduction: The Guillain-Barré syndrome is an acute inflammatory polyradiculoneuropathy that is characterized by a progressive pattern; within its possible etiology, there is an association between histories of viral and/or bacterial infection and
Edison Rodríguez-Coy Rodríguez-Coy +5 more
core +1 more source
Regional variation of Guillain-Barré syndrome
© 2018 The Author(s). Guillain-Barré syndrome is a heterogeneous disorder regarding the clinical presentation, electrophysiological subtype and outcome.
Barroso, Fabio A. +30 more
core +2 more sources
Background Guillain–Barré syndrome, a rare autoimmune polyneuropathy, typically follows infections and rarely surgical procedures. Post-surgical Guillain–Barré syndrome is an uncommon subset with significant clinical implications.
Amin Ahmed Kapadia +4 more
doaj +1 more source

